P669: Analysis of factors influencing the decision to stop TKI
treatment in CML patients in deep molecular response.

a 2023

P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.

SEMERÁD, Lukáš, Daniela ŽÁČKOVÁ, Petra BĚLOHLÁVKOVÁ, Jaroslava VOGLOVÁ, Pavel ŽÁK et. al.

Basic information

Original name

P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.

Authors

SEMERÁD, Lukáš (203 Czech Republic, belonging to the institution), Daniela ŽÁČKOVÁ (203 Czech Republic, belonging to the institution), Petra BĚLOHLÁVKOVÁ (203 Czech Republic, belonging to the institution), Jaroslava VOGLOVÁ (203 Czech Republic, belonging to the institution), Pavel ŽÁK (203 Czech Republic, belonging to the institution), Edgar FABER (703 Slovakia, belonging to the institution), Tomáš PAPAJÍK (203 Czech Republic, belonging to the institution), I. SKOUMALOVÁ (203 Czech Republic), M. KARAS, P. JINDRA, H. KLAMOVÁ, C. ŠÁLEK, D. SRBOVÁ, H. ŽIŽKOVÁ, L. STEJSKAL, Olga ČERNÁ (203 Czech Republic), Eduard CMUNT (203 Czech Republic, belonging to the institution), Petra ČIČÁTKOVÁ (203 Czech Republic, belonging to the institution), Anežka KVETKOVÁ (703 Slovakia, belonging to the institution), Tomáš HORŇÁK (703 Slovakia, belonging to the institution), Ivana JEŽÍŠKOVÁ (203 Czech Republic, belonging to the institution), Tomáš JURČEK (203 Czech Republic, belonging to the institution), Barbora WEINBERGEROVÁ (203 Czech Republic, belonging to the institution), Jiřina PROCHÁZKOVÁ (203 Czech Republic, belonging to the institution), Kateřina MACHOVÁ POLÁKOVÁ (203 Czech Republic, belonging to the institution), Adam SVOBODNÍK (203 Czech Republic, belonging to the institution), Radka ŠTĚPÁNOVÁ (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution)

Edition

EHA 2023 in HemaSphere (2023), 2023

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30205 Hematology

Country of publisher

Germany

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/23:00131051

Organization unit

Faculty of Medicine

Keywords in English

CML; TKI treatment; deep molecular response

Abstract

V originále

Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - EHA 2023 in HemaSphere (2023) conference abstract.

Links

LM2023049, research and development project

Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu

Investor: Ministry of Education, Youth and Sports of the CR

LX22NPO5102, research and development project

Name: Národní ústav pro výzkum rakoviny (Acronym: NÚVR)

Investor: Ministry of Education, Youth and Sports of the CR, National institute for cancer research, 5.1 EXCELES

Citovat

SEMERÁD, Lukáš, Daniela ŽÁČKOVÁ, Petra BĚLOHLÁVKOVÁ, Jaroslava VOGLOVÁ, Pavel ŽÁK, Edgar FABER, Tomáš PAPAJÍK, I. SKOUMALOVÁ, M. KARAS, P. JINDRA, H. KLAMOVÁ, C. ŠÁLEK, D. SRBOVÁ, H. ŽIŽKOVÁ, L. STEJSKAL, Olga ČERNÁ, Eduard CMUNT, Petra ČIČÁTKOVÁ, Anežka KVETKOVÁ, Tomáš HORŇÁK, Ivana JEŽÍŠKOVÁ, Tomáš JURČEK, Barbora WEINBERGEROVÁ, Jiřina PROCHÁZKOVÁ, Kateřina MACHOVÁ POLÁKOVÁ, Adam SVOBODNÍK, Radka ŠTĚPÁNOVÁ and Jiří MAYER. P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response. In EHA 2023 in HemaSphere (2023). 2023.

@proceedings{2293216,
   author = {Semerád, Lukáš and Žáčková, Daniela and Bělohlávková, Petra and Voglová, Jaroslava and Žák, Pavel and Faber, Edgar and Papajík, Tomáš and Skoumalová, I. and Karas, M. and Jindra, P. and Klamová, H. and Šálek, C. and Srbová, D. and Žižková, H. and Stejskal, L. and Černá, Olga and Cmunt, Eduard and Čičátková, Petra and Kvetková, Anežka and Horňák, Tomáš and Ježíšková, Ivana and Jurček, Tomáš and Weinbergerová, Barbora and Procházková, Jiřina and Machová Poláková, Kateřina and Svobodník, Adam and Štěpánová, Radka and Mayer, Jiří},
   booktitle = {EHA 2023 in HemaSphere (2023)},
   keywords = {CML; TKI treatment; deep molecular response},
   language = {eng},
   title = {P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.},
   year = {2023}
}

TY  - CONF
ID  - 2293216
AU  - Semerád, Lukáš - Žáčková, Daniela - Bělohlávková, Petra - Voglová, Jaroslava - Žák, Pavel - Faber, Edgar - Papajík, Tomáš - Skoumalová, I. - Karas, M. - Jindra, P. - Klamová, H. - Šálek, C. - Srbová, D. - Žižková, H. - Stejskal, L. - Černá, Olga - Cmunt, Eduard - Čičátková, Petra - Kvetková, Anežka - Horňák, Tomáš - Ježíšková, Ivana - Jurček, Tomáš - Weinbergerová, Barbora - Procházková, Jiřina - Machová Poláková, Kateřina - Svobodník, Adam - Štěpánová, Radka - Mayer, Jiří
PY  - 2023
TI  - P669: Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response.
KW  - CML
KW  - TKI treatment
KW  - deep molecular response
N2  - Analysis of factors influencing the decision to stop TKI treatment in CML patients in deep molecular response - EHA 2023 in HemaSphere (2023) conference abstract.
ER  -

Detailed Information on Publication Record